MedTrace Logo

Time of Ventilation and Lung Function of Ventilated Patients Under Therapy With Dornase Alfa

NCT00204685 · Status: UNKNOWN · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 540

Last updated 2006-09-14

No results posted yet for this study

Summary

The purpose of this study is to determine whether Inhalation of Recombinant Human Deoxyribonuclease Shortens Ventilation Time in Mechanically Ventilated Adults

Conditions

  • Long Term Ventilation

Interventions

DRUG

dornase alfa

Sponsors & Collaborators

  • Joachim Riethmueller, Dr. med.

    collaborator UNKNOWN

  • University Hospital Tuebingen

    lead OTHER

Principal Investigators

  • Joachim Riethmueller, Dr. med. · University Children's Hospital Tuebingen

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-08-31
Completion
2006-07-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00204685 on ClinicalTrials.gov